Abstract:Background: Intratympanic injections of glucocorticoids have become increasingly common in the treatment of idiopathic sudden sensorineural hearing loss (ISSHL). However, due to their fast elimination, sustained applications have been suggested for local drug delivery to the inner ear. Materials and methods: The study is based on a retrospective chart review of patients treated for ISSHL at a single tertiary (university) referral center. We included patients who were treated with a solid, biodegradable, poly(D,L-lactic-co-glycolic acid) (PLGA)-based drug delivery system providing sustained delivery of dexamethasone extracochlear into the round window niche ( n = 15) or intracochlear into scala tympani ( n = 2) for tertiary therapy of ISSHL in patients without serviceable hearing after primary systemic and secondary intratympanic glucocorticoid therapy. We evaluated the feasibility and safety through clinical evaluation, histological examination, and functional tests [pure-tone threshold (PTA), word recognition scores (WRS)]. Results: With adequate surgical preparation of the round window niche, implantation was feasible in all patients. Histologic examination of the material in the round window niche showed signs of resorption without relevant inflammation or foreign body reaction to the implant. In patients where the basal part of scala tympani was assessable during later cochlear implantation, no pathological findings were found. In the patients with extracochlear application, average preoperative PTA was 84.7 dB HL (SD: 20.0) and 76.7 dB HL (SD: 16.7) at follow-up ( p = 0.08). The preoperative average maximum WRS was 14.6% (SD: 17.9) and 39.3% (SD: 30.7) at follow-up ( p = 0.11). Six patients (40%), however, reached serviceable hearing. The two patients with intracochlear application did not improve. Conclusion: The extracochlear application of the controlled release system in the round window niche and – based on limited observations - intracochlear implantation into scala tympani appears feasible and safe. Due to the uncontrolled study design, conclusions about the efficacy of the treatment are limited. These observations, however, may encourage the initiation of prospective controlled studies using biodegradable controlled release implants as drug delivery systems for the treatment of inner ear diseases.

Injectable Poloxamer Hydrogel Formulations for Intratympanic Delivery of Dexamethasone

Study on Dexamethasone Thermosensistivie in Situ Gel for Treating Deafness

Hyaluronic acid hydrogel sustains the delivery of dexamethasone across the round window membrane

Novel self-degradable prodrug blend thermogel for intratympanic drug delivery to treat inner ear diseases

Dexamethasone nanocrystals-embedded hydroxypropyl methylcellulose hydrogel increases cochlear delivery and attenuates hearing loss following intratympanic injection

Silk-coated dexamethasone non-spherical microcrystals for local drug delivery to inner ear

Biopolymer Lipid Hybrid Microcarrier for Transmembrane Inner Ear Delivery of Dexamethasone

PLGA-PEG-PLGA hydrogel for ocular drug delivery of dexamethasone acetate

Biosafety and potency of high-molecular-weight hyaluronic acid with intratympanic dexamethasone delivery for acute hearing loss

Sustained Intravitreal Delivery of Dexamethasone Using an Injectable and Biodegradable Thermogel.

A silk-based hydrogel containing dexamethasone and lipoic acid microcrystals for local delivery to the inner ear

PLA–PCL–PEG–PCL–PLA based micelles for improving the ocular permeability of dexamethasone: development, characterization, and in vitro evaluation

Assessment of the drug loading, in vitro and in vivo release behavior of novel pH-sensitive hydrogel

The Pharmacokinetic Profiles of Dexamethasone and Methylprednisolone Concentration in Perilymph and Plasma Following Systemic and Local Administration

Mastoid approach for local drug delivery to the inner ear for treating hearing loss

Safety and audiological outcome in a case series of tertiary therapy of sudden hearing loss with a biodegradable drug delivery implant for controlled release of dexamethasone to the inner ear

Microfluidic Preparation of Gelatin Methacryloyl Microgels As Local Drug Delivery Vehicles for Hearing Loss Therapy.

The Preparation of Dexamethasone Sodium Phosphate Multivesicular Liposomes Thermosensative Hydrogel and Its Impact on Noise-Induced Hearing Loss in the Guinea Pigs.

Biodegradable dexamethasone polymer capsule for long-term release

Mucoadhesive Poloxamer-Based Hydrogels for the Release of HP-β-CD-Complexed Dexamethasone in the Treatment of Buccal Diseases

Dexamethasone release from hyaluronic acid microparticle and proanthocyanidin-gelatin hydrogel in sciatic tissue regeneration